CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

CUSIP: 18914F103

Q3 2021 13F Holders as of 30 Sep 2021

Holder snapshot 7 signals
Share change
-36,300,856
Put/Call ratio
64%
SEC-reported price per share
$7.39
Number of holders
131
Value change
-$325,418,528
Number of buys
84
Open additional details 1 more signal available
Number of sells
54
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
416,598,522

Security key

18914F103

Report period

Q3 2021

Institutions

131

Top holders

10

Ownership snapshot

Top reported holders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Chamath Palihapitiya
Disclosed value leader
GREENOAKS LLC
Comparable rows
0/15
Latest evidence
07 Jul 2021
3/4/5 13F Highest disclosed value: $1,283,133,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

GREENOAKS LLC has the largest disclosed position value at $1.28B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GREENOAKS LLC's linked filing trail.
Disclosed position value Top 5
Chamath Palihapitiya $29.54M
GREENOAKS LLC $1.28B
VANGUARD GROUP INC $126.94M
BAILLIE GIFFORD & CO $68.49M
FMR LLC $56.23M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Chamath Palihapitiya
3/4/5
FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner
—
denominator unverified
$29,544,657
30,147,610 shares
— 07 Jul 2021
GREENOAKS LLC
13F
Company
13F
—
denominator unverified
$1,283,133,000
96,331,338 shares
— 30 Jun 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$126,936,000
9,529,811 shares
— 30 Jun 2021
BAILLIE GIFFORD & CO
13F
Company
13F
—
denominator unverified
$68,494,000
5,142,177 shares
— 30 Jun 2021
FMR LLC
13F
Company
13F
—
denominator unverified
$56,229,000
4,260,237 shares
— 30 Jun 2021
Alphabet Inc.
13F
Company
13F
—
denominator unverified
$54,795,000
4,113,742 shares
— 30 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
131
Shares
105,648,029
Rows available
131
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
132
Q3 2021 holders
131
Holder diff
-1
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .